Director BMT and Cellular Therapy Oncologist - OHC Cincinnati

The US Oncology Network; Cincinnati (OH); On-site; USD 200,000 - 300,000; Full time

Job summary

An established industry player is seeking a seasoned Cellular Therapy and BMT physician to lead its department in Cincinnati, Ohio. This role offers the opportunity to drive program development and enhance patient care in a supportive environment. With over 30 years of expertise and a robust research pipeline, the organization is committed to delivering high-quality, compassionate cancer care. Physicians will enjoy a competitive compensation package, a pathway to partnership, and a collaborative team focused on excellence in patient outcomes. Join a dedicated team and make a significant impact in the field of oncology.

Benefits

Competitive compensation package

Profit sharing

Pathway to partnership

Comprehensive benefits

Dedicated administrative support

Qualifications

• Experience in leading hematology and oncology practices.
• Strong background in cellular therapy and BMT.

Responsibilities

• Lead the BMT department and develop strategic direction.
• Manage autologous and allogeneic transplants and CAR-T therapies.

Skills

Cellular Therapy

BMT (Bone Marrow Transplant)

Clinical Research

Oncology Expertise

Education

Medical Degree (MD or DO)

Board Certification in Hematology/Oncology

Job description

OHC (Oncology Hematology Care) - Cellular Therapy & BMT Physician Opportunity

OHC is a well-established provider in the BMT and Cellular Therapy space, supported by skilled oncologists, hospitalists, and advanced practice providers (APPs). We are seeking a seasoned Cellular Therapy and BMT physician to lead our department into its next growth phase. Partnering with US Oncology and as part of a private practice oncology group, the chosen candidate will have the autonomy and support to develop the program to best serve patient and community needs.

OHC is a FACT-accredited BMT practice located in Cincinnati, Ohio, with over 30 years of experience in transplant and cell therapy, having completed approximately 3,000 cellular therapy procedures. The leader will set strategic direction and serve as the clinical head to manage autologous and allogeneic transplants, commercial CAR-T, research studies involving allogenic CAR/NK cell therapy, and bispecific antibodies. As part of The US Oncology Network, the team benefits from robust administrative and operational support. The BMT team also collaborates with a strong phase 1-3 research pipeline in hematologic malignancies and partners with the Sarah Cannon Research Institute.

Our mission at OHC is to deliver the highest quality, cost-effective, and compassionate cancer care close to home. With more than 50 physicians and advanced practice providers, we specialize in treating adults with a wide range of cancers and complex blood disorders. Our physicians are recognized experts in medical and radiation oncology, gynecologic oncology, neuro-oncology, blood and marrow transplant services, and palliative care. We also have a dedicated clinical research team experienced in conducting trials as part of The US Oncology Network.

OHC offers physicians a 4.5-day hematology-focused clinic and inpatient schedule supported by APPs, including a half-day dedicated to administrative duties. We provide a competitive compensation package with a pathway to partnership within two years or less, comprehensive benefits including profit sharing, and a dedicated team committed to quality patient care. For more information, visit: https://www.ohcare.com/